Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P0C1Z6

Entry ID Method Resolution Chain Position Source
AF-P0C1Z6-F1 Predicted AlphaFoldDB

236 variants for P0C1Z6

Variant ID(s) Position Change Description Diseaes Association Provenance
CA407788171
rs1193141793
5 Q>H No ClinGen
TOPMed
CA407788174
rs1180763350
5 Q>R No TOPMed
gnomAD
ClinGen
rs1458028512
CA407788157
7 E>Q No ClinGen
gnomAD
CA407788140
rs1239984117
8 G>E No gnomAD
ClinGen
rs777367685
CA309317822
9 T>S No ExAC
gnomAD
ClinGen
rs1192822450
CA407788039
10 M>I No gnomAD
ClinGen
rs1474507713
CA407788037
11 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No gnomAD
ClinGen
NCI-TCGA
CA407788027
rs1241584778
12 A>P No gnomAD
ClinGen
CA309317808
rs754380542
13 V>A No ExAC
gnomAD
ClinGen
CA407787987
rs1313116720
15 F>S No gnomAD
ClinGen
rs750853355
CA309317796
17 E>D No ExAC
gnomAD
ClinGen
CA309317793
rs376999253
18 F>L No ESP
ExAC
gnomAD
ClinGen
rs1336894892
CA407787919
19 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No gnomAD
ClinGen
NCI-TCGA
CA407787879
rs1381300743
21 P>L No TOPMed
ClinGen
CA309317770
rs587617418
24 S>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA309317769
rs762884888
25 E>D No ExAC
gnomAD
ClinGen
rs1157014752
CA407787752
27 A>T No TOPMed
ClinGen
CA309317754
rs781018410
28 L>M No ExAC
TOPMed
gnomAD
ClinGen
rs1454715686
CA407787589
34 G>D No gnomAD
ClinGen
rs747676603
CA309317657
41 L>P No ExAC
gnomAD
ClinGen
CA407787331
rs1368887473
44 E>G No TOPMed
ClinGen
TCGA novel 44 E>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 45 V>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1255721224
CA407787240
49 S>T No ClinGen
gnomAD
rs960809894
CA309317627
51 G>S No TOPMed
ClinGen
CA407787145
rs1309970433
52 L>R No TOPMed
ClinGen
CA309317612
rs373003232
54 G>S No ESP
ExAC
TOPMed
gnomAD
ClinGen
CA407787073
rs1437718116
55 S>* No gnomAD
ClinGen
CA309317604
rs928059728
56 G>E No Ensembl
ClinGen
CA407787041
rs1256897300
57 L>I No gnomAD
ClinGen
CA407787036
rs1185242712
57 L>P No gnomAD
ClinGen
CA407787026
rs1310254845
58 R>G No TOPMed
gnomAD
ClinGen
CA309317585
rs757494817
58 R>Q No ClinGen
ExAC
gnomAD
CA407786959
rs1227376487
60 R>P No gnomAD
ClinGen
CA407786929
rs201672137
61 D>E No 1000Genomes
ExAC
TOPMed
gnomAD
ClinGen
rs139955385
CA309317568
63 E>D No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
ClinGen
CA407786885
rs1394523441
63 E>K No TOPMed
ClinGen
TCGA novel 64 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1399519424
CA407786846
64 E>D No gnomAD
ClinGen
rs763233664
CA309317552
64 E>Q No ExAC
TOPMed
gnomAD
ClinGen
TCGA novel 65 E>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA309317526
rs770740513
68 R>Q No ExAC
TOPMed
gnomAD
ClinGen
rs1467307059
CA407786758
68 R>W No gnomAD
ClinGen
CA309317519
rs759494963
69 G>S No ExAC
gnomAD
ClinGen
rs146000517
CA309317509
69 G>V No ESP
TOPMed
ClinGen
CA407786706
COSM1326190
rs1162947527
70 R>Q ovary Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No TOPMed
ClinGen
cosmic curated
NCI-TCGA
rs1209744902
CA407786707
70 R>W No TOPMed
gnomAD
ClinGen
CA309317493
rs776513954
71 R>P No ExAC
gnomAD
ClinGen
rs776513954
CA309317497
71 R>Q No ExAC
gnomAD
ClinGen
rs746834418
CA309317470
74 Q>R No ExAC
ClinGen
CA407786580
rs1568574351
75 R>P No Ensembl
ClinGen
CA407786526
rs1302736933
77 L>S No ClinGen
gnomAD
rs587648855
CA309317469
78 N>H No 1000Genomes
ExAC
gnomAD
ClinGen
rs1568574320
CA407786495
78 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No Ensembl
ClinGen
NCI-TCGA
CA309317468
rs771658243
79 R>C No ClinGen
ExAC
gnomAD
CA309317466
rs747776427
79 R>L No ExAC
TOPMed
ClinGen
TCGA novel 82 Y>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1399388261
TCGA novel
CA407786333
84 A>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TOPMed
ClinGen
rs1389639177
CA407786281
87 R>Q No TOPMed
ClinGen
CA407786290
rs1212332415
87 R>W No gnomAD
ClinGen
CA309317449
rs754496341
88 R>G No ExAC
gnomAD
ClinGen
rs781740615
CA309317431
90 R>L No ExAC
gnomAD
ClinGen
rs781740615
CA407786217
90 R>Q No ExAC
gnomAD
ClinGen
rs142515991
CA309317443
90 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ESP
ExAC
TOPMed
gnomAD
ClinGen
NCI-TCGA
rs587751545
CA309317425
91 E>K No 1000Genomes
ExAC
gnomAD
ClinGen
rs752870810
CA309317419
92 I>M No ExAC
gnomAD
ClinGen
rs758601188
CA309317423
92 I>T No ExAC
TOPMed
ClinGen
CA407786149
rs1568574190
93 E>* No Ensembl
ClinGen
CA407786130
rs1291130439
94 Q>* No TOPMed
ClinGen
CA309313720
rs372825631
95 V>M No ESP
ExAC
gnomAD
ClinGen
CA407784498
COSM713810
rs1051140983
CA309313710
96 N>K lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No TOPMed
gnomAD
ClinGen
cosmic curated
NCI-TCGA
rs761642321
CA309313700
97 E>G No ExAC
gnomAD
ClinGen
CA407784495
rs767220147
97 E>K No ExAC
TOPMed
gnomAD
ClinGen
rs767220147
CA407784493
97 E>Q No ClinGen
ExAC
TOPMed
gnomAD
rs774272913
CA309313697
98 R>Q No ExAC
TOPMed
gnomAD
ClinGen
rs1600297864
CA407784465
99 V>G No Ensembl
ClinGen
rs1263660453
CA407784446
101 N>S No TOPMed
gnomAD
ClinGen
CA309313671
rs774912384
102 R>G No ExAC
gnomAD
ClinGen
CA407784435
rs1244070857
102 R>K No TOPMed
ClinGen
CA309313664
rs369765889
102 R>S No ESP
ExAC
TOPMed
gnomAD
ClinGen
rs1233867142
CA407784421
103 L>H No gnomAD
ClinGen
CA407784407
rs1293444922
104 H>R No gnomAD
ClinGen
rs940733213
CA309313649
105 Q>H No Ensembl
ClinGen
CA309313641
rs772441947
106 V>L No ExAC
gnomAD
ClinGen
CA309313635
rs772441947
106 V>M No ExAC
gnomAD
ClinGen
TCGA novel 108 R>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs200361982
CA407784331
111 R>G No 1000Genomes
ExAC
TOPMed
gnomAD
ClinGen
CA309313608
rs375419473
111 R>Q No ESP
TOPMed
ClinGen
rs200361982
CA309313611
111 R>W No 1000Genomes
ExAC
TOPMed
gnomAD
ClinGen
CA407784320
rs1273545952
112 R>K No gnomAD
ClinGen
CA407784313
rs1600297644
112 R>S No Ensembl
ClinGen
CA407784289
rs1220428572
114 Q>H No TOPMed
gnomAD
ClinGen
CA309313602
rs138024173
115 Q>H No ESP
ExAC
TOPMed
gnomAD
ClinGen
rs150437143
CA309313591
116 E>Q No ESP
ExAC
TOPMed
gnomAD
ClinGen
rs750339337
CA407784251
117 R>G No ExAC
TOPMed
gnomAD
ClinGen
rs761840525
CA309313539
117 R>L No ExAC
gnomAD
ClinGen
rs761840525
CA309313550
117 R>Q No ExAC
gnomAD
ClinGen
CA309313570
rs750339337
117 R>W No ExAC
TOPMed
gnomAD
ClinGen
rs751442251
CA309313510
118 R>T No ExAC
gnomAD
ClinGen
TCGA novel 120 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA309311793
rs753500915
121 M>K No ExAC
gnomAD
ClinGen
rs753500915
CA309311791
121 M>T No ExAC
gnomAD
ClinGen
CA407782540
rs751160649
CA407782543
123 V>L No ExAC
gnomAD
ClinGen
rs751160649
CA407782545
123 V>M No ExAC
gnomAD
ClinGen
TCGA novel 126 S>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs970875427
CA309311772
127 Y>C No gnomAD
ClinGen
CA309311779
rs755756976
127 Y>H No ExAC
TOPMed
gnomAD
ClinGen
CA407782445
rs1360427920
128 G>R No Ensembl
ClinGen
rs1374391939
CA407782427
129 D>N No gnomAD
ClinGen
CA309311750
rs141461777
131 Y>C No ESP
ExAC
gnomAD
ClinGen
CA309311747
rs753104719
132 R>Q No ExAC
TOPMed
gnomAD
ClinGen
CA309311748
rs148303725
132 R>W No ESP
ExAC
TOPMed
gnomAD
ClinGen
rs1443447059
CA407782311
136 F>L No gnomAD
ClinGen
rs1281320796
CA407782279
138 I>F No gnomAD
ClinGen
CA309311713
rs777126350
138 I>M No ExAC
gnomAD
ClinGen
CA309311715
rs759925165
138 I>T No ExAC
TOPMed
gnomAD
ClinGen
CA407782245
rs1277243567
140 L>P No gnomAD
ClinGen
rs1277243567
CA407782242
140 L>R No gnomAD
ClinGen
CA407782125
rs1387396149
142 D>H No gnomAD
ClinGen
CA309311571
rs761006755
142 D>V No ClinGen
ExAC
CA309311566
rs773236546
143 E>* No ExAC
ClinGen
rs767644731
CA309311561
143 E>D No ClinGen
ExAC
gnomAD
rs1272376789
CA407782075
144 G>D No ClinGen
TOPMed
rs761856411
CA309311557
144 G>S No ExAC
TOPMed
gnomAD
ClinGen
CA407782068
rs1237063641
145 S>R No TOPMed
gnomAD
ClinGen
rs1055973936
CA309311549
146 Q>E No Ensembl
ClinGen
rs1448407063
CA407782037
146 Q>R No TOPMed
ClinGen
CA407782026
rs1481313637
147 G>A No gnomAD
ClinGen
CA407782028
rs1481313637
147 G>D No ClinGen
gnomAD
CA407782031
rs1286254299
147 G>S No TOPMed
gnomAD
ClinGen
CA309311544
rs375487904
148 T>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA407781998
rs1322123023
150 A>P No TOPMed
gnomAD
ClinGen
rs1322123023
CA407782000
150 A>T No TOPMed
gnomAD
ClinGen
rs1182793122
CA407781988
151 P>S No TOPMed
ClinGen
CA407781979
rs1311809936
152 T>A No TOPMed
gnomAD
ClinGen
rs769539637
CA309311496
152 T>I No ExAC
gnomAD
ClinGen
CA407781977
rs1311809936
152 T>S No TOPMed
gnomAD
ClinGen
CA309311485
rs761143770
153 P>S No Ensembl
ClinGen
rs780651901
CA309311478
154 G>D No ExAC
TOPMed
gnomAD
ClinGen
CA407781932
rs1365575190
155 N>D No gnomAD
ClinGen
CA407781907
rs1232104130
155 N>S No gnomAD
ClinGen
rs201891249
CA407781888
156 A>E No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
ClinGen
rs201891249
CA309311472
156 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
ClinGen
NCI-TCGA
CA407781881
rs200459700
157 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA407781879
rs200459700
157 E>Q No ESP
ExAC
TOPMed
gnomAD
ClinGen
rs1381524737
CA407781853
158 N>I No gnomAD
ClinGen
CA407781858
rs1419446436
158 N>Y No gnomAD
ClinGen
CA407781824
rs1420421950
160 P>H No gnomAD
ClinGen
rs1288625916
CA407781776
163 K>E No TOPMed
gnomAD
ClinGen
rs766850986
CA309311445
163 K>R No ExAC
gnomAD
ClinGen
CA407781744
rs1220264646
164 E>D No TOPMed
ClinGen
rs756487327
CA309311430
165 T>A No ExAC
gnomAD
ClinGen
CA309311401
rs767698135
166 L>P No ExAC
TOPMed
gnomAD
ClinGen
CA309311392
rs762062470
167 S>P No ClinGen
ExAC
TOPMed
gnomAD
rs774342975
CA309311386
168 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ExAC
TOPMed
gnomAD
ClinGen
NCI-TCGA
CA407781672
rs762910213
169 P>A No ExAC
TOPMed
gnomAD
ClinGen
rs762910213
CA309311362
169 P>S No ExAC
TOPMed
gnomAD
ClinGen
rs769591725
CA309311340
170 R>K No ExAC
TOPMed
gnomAD
ClinGen
rs1361561872
CA407781595
173 P>L No gnomAD
ClinGen
rs1291143443
CA407781588
174 A>T No gnomAD
ClinGen
rs1375463024
CA407781567
175 P>L No gnomAD
ClinGen
rs142642138
CA309311315
175 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ESP
ExAC
TOPMed
gnomAD
ClinGen
NCI-TCGA
CA407781556
rs1480466945
176 P>Q No TOPMed
gnomAD
ClinGen
rs1480466945
CA407781553
176 P>R No TOPMed
gnomAD
ClinGen
CA309311313
rs770531913
176 P>T No ExAC
gnomAD
ClinGen
CA407781504
rs1191059293
179 G>S No TOPMed
gnomAD
ClinGen
rs749824870
CA309311295
182 A>D No ExAC
TOPMed
gnomAD
ClinGen
rs749824870
CA407781422
182 A>G No ExAC
TOPMed
gnomAD
ClinGen
rs749824870
CA309311294
182 A>V No ExAC
TOPMed
gnomAD
ClinGen
CA407781401
rs1259651286
183 P>H No gnomAD
ClinGen
rs1434803502
CA407781406
183 P>S No gnomAD
ClinGen
rs370305737
CA309311286
184 G>D No ESP
ExAC
TOPMed
gnomAD
ClinGen
CA309311290
rs200020589
184 G>S No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
ClinGen
rs1568564339
CA407781296
187 P>S No Ensembl
ClinGen
CA309311270
rs762965314
189 G>V No ExAC
gnomAD
ClinGen
CA309311259
rs371509951
190 R>Q No ESP
ExAC
TOPMed
gnomAD
ClinGen
CA309311260
COSM1229061
rs765229548
190 R>W large_intestine [Cosmic] No ExAC
TOPMed
gnomAD
ClinGen
cosmic curated
rs770714341
CA407781174
192 R>K No ExAC
TOPMed
gnomAD
ClinGen
rs770714341
CA407781170
192 R>M No ExAC
TOPMed
gnomAD
ClinGen
rs368833895
CA407781162
193 R>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs147735140
CA309311247
193 R>Q No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
ClinGen
CA309311256
rs368833895
193 R>W No ESP
ExAC
TOPMed
gnomAD
ClinGen
CA309311211
rs747723515
194 R>* No ExAC
TOPMed
gnomAD
ClinGen
CA309311205
rs587666544
194 R>Q No 1000Genomes
ExAC
TOPMed
gnomAD
ClinGen
CA407781148
rs1195110017
195 V>M No ClinGen
gnomAD
CA309311177
rs200497052
197 R>Q No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
ClinGen
rs372980800
CA309311181
197 R>W No ExAC
TOPMed
gnomAD
ClinGen
CA309311172
rs781439874
199 G>R No ExAC
gnomAD
ClinGen
CA309311166
rs140973668
200 R>C No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs751744667
CA309311160
200 R>H No ExAC
TOPMed
gnomAD
ClinGen
rs751744667
CA407781051
200 R>L No ExAC
TOPMed
gnomAD
ClinGen
TCGA novel 200 R>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA309311155
rs778029287
201 R>* No ExAC
TOPMed
gnomAD
ClinGen
rs587639297
CA407781018
201 R>P No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs587639297
CA407781024
201 R>Q No 1000Genomes
ExAC
TOPMed
gnomAD
ClinGen
rs1300696950
CA407780922
204 N>K No TOPMed
ClinGen
CA407780908
rs545448952
205 A>G Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No 1000Genomes
ExAC
TOPMed
gnomAD
ClinGen
NCI-TCGA
CA309311132
rs545448952
205 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No 1000Genomes
ExAC
TOPMed
gnomAD
ClinGen
NCI-TCGA
CA309311119
rs753773339
206 L>P No ExAC
TOPMed
gnomAD
ClinGen
rs760574312
CA407780857
207 T>I No ExAC
gnomAD
ClinGen
rs760574312
CA309311104
207 T>N No ExAC
gnomAD
ClinGen
rs766098166
CA309311116
207 T>P No ExAC
gnomAD
ClinGen
CA407780776
rs1169269396
211 A>T No gnomAD
ClinGen
CA407780737
rs1295398705
212 P>A No TOPMed
gnomAD
ClinGen
CA309311093
rs201832670
212 P>L No 1000Genomes
ExAC
TOPMed
gnomAD
ClinGen
rs774020839
CA309311087
213 V>E No ClinGen
ExAC
gnomAD
CA407779128
rs1397198376
215 I>M No TOPMed
gnomAD
ClinGen
rs897235839
CA309310537
215 I>T No gnomAD
ClinGen
CA309310532
rs755146722
217 V>A No ExAC
gnomAD
ClinGen
CA309310533
rs761247321
217 V>I No ExAC
TOPMed
gnomAD
ClinGen
rs1358318073
CA407779091
218 E>K No gnomAD
ClinGen
CA407779081
rs1167210836
219 E>K No gnomAD
ClinGen
CA309310507
rs149913762
220 D>Y No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs139073279
CA309310501
223 F>S No ESP
ExAC
TOPMed
gnomAD
ClinGen
rs756140239
CA309310496
224 E>* No ExAC
gnomAD
ClinGen
CA309310486
rs750346120
225 A>G No ExAC
gnomAD
ClinGen
rs767423431
CA309310473
228 A>V No ExAC
gnomAD
ClinGen
CA407778779
rs587748485
236 R>P No 1000Genomes
ExAC
TOPMed
gnomAD
ClinGen
rs587748485
CA309310436
236 R>Q No 1000Genomes
ExAC
TOPMed
gnomAD
ClinGen
rs763875464
CA309310442
236 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ExAC
TOPMed
gnomAD
ClinGen
NCI-TCGA
CA407778772
rs1283536632
237 G>S No gnomAD
ClinGen
CA407778749
rs1224909501
238 P>R No gnomAD
ClinGen
CA309310411
rs764606714
244 Y>* No ExAC
TOPMed
gnomAD
ClinGen
rs369757230
CA309310402
245 P>L No ESP
ExAC
TOPMed
gnomAD
ClinGen
rs369757230
CA309310406
245 P>Q No ESP
ExAC
TOPMed
gnomAD
ClinGen
CA407778634
rs369757230
245 P>R No ESP
ExAC
TOPMed
gnomAD
ClinGen
CA407778639
rs1431156512
245 P>S No gnomAD
ClinGen
CA407778621
rs1468951447
246 T>I No TOPMed
ClinGen
CA407778628
rs1469414268
246 T>P No gnomAD
ClinGen
rs576494595
CA309310390
248 A>T No Ensembl
ClinGen
rs34939501
CA309310366
251 A>G No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
ClinGen
rs151148202
CA309310372
251 A>S No ESP
ExAC
TOPMed
gnomAD
ClinGen
CA309310349
rs780212681
253 D>A No ExAC
gnomAD
ClinGen
CA309310344
rs769926922
253 D>E No ExAC
gnomAD
ClinGen
rs749420696
CA309310354
253 D>H No ExAC
TOPMed
gnomAD
ClinGen
rs749420696
CA407778513
253 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ExAC
TOPMed
gnomAD
ClinGen
NCI-TCGA

No associated diseases with P0C1Z6

1 regional properties for P0C1Z6

Type Name Position InterPro Accession
domain Tubulin epsilon and delta complex protein 1 domain 86 - 256 IPR027996

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
actin filament A filamentous structure formed of a two-stranded helical polymer of the protein actin and associated proteins. Actin filaments are a major component of the contractile apparatus of skeletal muscle and the microfilaments of the cytoskeleton of eukaryotic cells. The filaments, comprising polymerized globular actin molecules, appear as flexible structures with a diameter of 5-9 nm. They are organized into a variety of linear bundles, two-dimensional networks, and three dimensional gels. In the cytoskeleton they are most highly concentrated in the cortex of the cell just beneath the plasma membrane.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
Ino80 complex A multisubunit protein complex that contains the Ino80p ATPase; exhibits chromatin remodeling activity.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

3 GO annotations of molecular function

Name Definition
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
protein kinase binding Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
protein-containing complex binding Binding to a macromolecular complex.

15 GO annotations of biological process

Name Definition
apoptotic signaling pathway The series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered.
chromatin remodeling A dynamic process of chromatin reorganization resulting in changes to chromatin structure. These changes allow DNA metabolic processes such as transcriptional regulation, DNA recombination, DNA repair, and DNA replication.
DNA recombination Any process in which a new genotype is formed by reassortment of genes resulting in gene combinations different from those that were present in the parents. In eukaryotes genetic recombination can occur by chromosome assortment, intrachromosomal recombination, or nonreciprocal interchromosomal recombination. Interchromosomal recombination occurs by crossing over. In bacteria it may occur by genetic transformation, conjugation, transduction, or F-duction.
DNA repair The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway.
male gonad development The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
positive regulation of apoptotic process Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
positive regulation of DNA repair Any process that activates or increases the frequency, rate or extent of DNA repair.
positive regulation of DNA-templated transcription Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
positive regulation of telomere maintenance in response to DNA damage Any process that activates or increases the frequency, rate or extent of telomere maintenance in response to DNA damage.
regulation of cell cycle Any process that modulates the rate or extent of progression through the cell cycle.
regulation of chromosome organization Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a chromosome.
regulation of DNA replication Any process that modulates the frequency, rate or extent of DNA replication.
regulation of DNA strand elongation Any process that modulates the rate, frequency or extent of DNA strand elongation. DNA strand elongation is the DNA metabolic process in which an existing DNA strand is extended by activities including the addition of nucleotides to the 3' end of the strand.
regulation of embryonic development Any process that modulates the frequency, rate or extent of embryonic development.
telomere maintenance Any process that contributes to the maintenance of proper telomeric length and structure by affecting and monitoring the activity of telomeric proteins, the length of telomeric DNA and the replication and repair of the DNA. These processes includes those that shorten, lengthen, replicate and repair the telomeric DNA sequences.

3 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q17QH7 TFPT TCF3 fusion partner homolog Bos taurus (Bovine) PR
Q3U1J1 Tfpt TCF3 fusion partner homolog Mus musculus (Mouse) PR
Q9JMG6 Tfpt TCF3 fusion partner homolog Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MELEQREGTM AAVGFEEFSA PPGSELALPP LFGGHILESE LETEVEFVSG GLGGSGLRER
70 80 90 100 110 120
DEEEEAARGR RRRQRELNRR KYQALGRRCR EIEQVNERVL NRLHQVQRIT RRLQQERRFL
130 140 150 160 170 180
MRVLDSYGDD YRASQFTIVL EDEGSQGTDA PTPGNAENEP PEKETLSPPR RTPAPPEPGS
190 200 210 220 230 240
PAPGEGPSGR KRRRVPRDGR RAGNALTPEL APVQIKVEED FGFEADEALD SSWVSRGPDK
250
LLPYPTLASP ASD